Your browser doesn't support javascript.
loading
HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program.
Ndenkeh, Jackson Jr Nforbewing; Bowring, Anna L; Njindam, Iliassou Mfochive; Folem, Romeo Dongfack; Fako, Guy Christian Hendji; Ngueguim, Florent Gnintedem; Gayou, Oscar Leyou; Lepawa, Kelly; Minka, Christine Minka; Batoum, Christine Manyo; Georges, Sandra; Temgoua, Edith; Nzima, Valery; Kob, David Anouar; Akiy, Zacheus Zeh; Philbrick, William; Levitt, Daniel; Curry, Dora; Baral, Stefan.
Afiliación
  • Ndenkeh JJN; Care International in Cameroon, Yaoundé, Cameroon.
  • Bowring AL; CIH Center for International Health, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.
  • Njindam IM; Burnet Institute, Melbourne, Australia.
  • Folem RD; John Hopkins School of Public Health, Baltimore, USA.
  • Fako GCH; John Hopkins School of Public Health, Baltimore, USA.
  • Ngueguim FG; Care International in Cameroon, Yaoundé, Cameroon.
  • Gayou OL; Care International in Cameroon, Yaoundé, Cameroon.
  • Lepawa K; Care International in Cameroon, Yaoundé, Cameroon.
  • Minka CM; Care International in Cameroon, Yaoundé, Cameroon.
  • Batoum CM; Care and Health Program (CHP), Yaoundé, Cameroon.
  • Georges S; Care International in Cameroon, Yaoundé, Cameroon.
  • Temgoua E; Care International in Cameroon, Yaoundé, Cameroon.
  • Nzima V; Care International in Cameroon, Yaoundé, Cameroon.
  • Kob DA; National AIDS Control Committee (NACC), Yaoundé, Cameroon.
  • Akiy ZZ; United States Agency for International Development (USAID), Yaoundé, Cameroon ; and.
  • Philbrick W; United States Agency for International Development (USAID), Yaoundé, Cameroon ; and.
  • Levitt D; United States Agency for International Development (USAID), Yaoundé, Cameroon ; and.
  • Curry D; CARE USA, Atlanta, USA.
  • Baral S; CARE USA, Atlanta, USA.
J Acquir Immune Defic Syndr ; 91(1): 39-46, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35536113
INTRODUCTION: Pre-exposure prophylaxis (PrEP) is proven to be a highly effective HIV prevention method for key populations. However, its scale-up in resource-limited settings remains suboptimal. This paper seeks to describe PrEP initiation and continuation among key populations in Cameroon. METHODOLOGY: From June 2019 through October 2020, we collected routine program data on PrEP uptake and continuation among female sex workers (FSWs) and men who have sex with men (MSM) in the Continuum of prevention, care and treatment of HIV/AIDS with Most-at-risk Populations (CHAMP) program in Cameroon. PrEP was offered to clients who tested negative for HIV and were assessed to potentially benefit from PrEP. Using survival analysis, we identified factors associated with PrEP discontinuation over time with significance set at 5%. RESULTS: Overall, 27,750 clients were sensitized for PrEP of whom 3,138 persons were eligible to start PrEP and 1,409 (45%; FSW: 691 and MSM: 718) initiated PrEP. The PrEP continuation rate was 37% at 3 months, 28% at 6 months and 19% at 12 months. PrEP discontinuation was significantly higher among FSW than MSM [adjusted hazard ratio (aHR) 1.5 (95% CI: 1.2 to 1.9)] in Yaounde [aHR 1.5 (95% CI: 1.2 to 1.9)] and Bafoussam/Bertoua [aHR 3.1 (2.2-4.5)] relative to Douala. Discontinuation was lower among those with moderate [aHR 0.3 (0.3-0.4)] or good adherence [aHR 0.4 (0.3-0.6)] compared with poor adherence (all P < 0.001). CONCLUSION: Differentiated approaches to deliver PrEP, create demand, and provide more intensive support for adherence and continuation may support scale-up of PrEP in Cameroon for equitable and prolonged impact on HIV prevention.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Trabajadores Sexuales / Profilaxis Pre-Exposición / Minorías Sexuales y de Género Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Camerún

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Trabajadores Sexuales / Profilaxis Pre-Exposición / Minorías Sexuales y de Género Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Camerún